Efficacy and safety of palifermin in a large cohort of patients with haematological malignancies undergoing autologous haematopoietic stem cell transplantation

被引：0
|
作者：
Cavagna, L.
Rossi, G.
Saglio, G.
Pilatrino, C.
Petti, M.
Mengarelli, A.
Meloni, G.
Capria, S.
Visani, G.
Isidori, A.
Benincasa, E.
机构：
[1] Amgen Inc, Milan, Italy
[2] Osped Civile, Brescia, Italy
[3] Osped San Luigi, Orbassano, Italy
[4] INT, Rome, Italy
[5] Univ Roma La Sapienza, Rome, Italy
[6] Osped San Salvatore, Pesaro, Italy
来源：
BONE MARROW TRANSPLANTATION | 2007年 / 39卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S212 / S212
页数：1
相关论文
共 50 条
  • [1] Incidence of acute enterocolitis in patients with haematological malignancies receiving autologous stem cell transplantation - the Palifermin experience
    Sousa, I.
    Geraldes, C.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S292 - S293
  • [2] Recommendations for palifermin use in the prevention of oral mucositis in patients undergoing haematological autologous stem cell transplantation
    Olivieri, A.
    Gallo, E.
    Rossi, G.
    Borsani, L.
    Cavagna, L.
    Deliliers, G. Lambertenghi
    BONE MARROW TRANSPLANTATION, 2008, 41 : S100 - S101
  • [3] Echinocandin prophylaxis in patients undergoing haematopoietic cell transplantation and other treatments for haematological malignancies
    Epstein, David J.
    Seo, Susan K.
    Brown, Janice M.
    Papanicolaou, Genovefa A.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2018, 73 : i60 - i72
  • [4] Nitrogen balance in patients undergoing autologous haematopoietic stem cell transplantation
    Novik, A. A.
    Matyshevskaya, V. N.
    Melnichenko, V. Y.
    Fedorenko, D. A.
    Ionova, T. I.
    Trifonov, S. I.
    Kim, K. F.
    Sysoeva, T. S.
    Gorodokin, G.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S176 - S177
  • [5] Efficacy and safety of lipegfilgrastim in patients with lymphoproliferative malignancies after autologous stem cell transplantation
    Stefanko, E.
    Rybka, J.
    Deren-Wagemann, I.
    Biedron, M.
    Urbaniak-Kujda, D.
    Dybka, J.
    Poreba, R.
    Kuliczkowski, K.
    Wrobel, T.
    BONE MARROW TRANSPLANTATION, 2015, 50 : 5620 - 5620
  • [6] Long-Term Safety Outcomes in Patients with Hematological Malignancies Undergoing Autologous Hematopoietic Stem Cell Transplantation Treated with Palifermin to Prevent Oral Mucositis
    Stiff, Patrick J.
    Leinonen, Mika
    Kullenberg, Torbjorn
    Rudebeck, Mattias
    de Chateau, Maarten
    Spielberger, Ricardo
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (01) : 164 - 169
  • [7] Pegfilgrastim shows safety and efficacy similar to filgrastim in patients undergoing autologous stem cell transplantation for hematological malignancies.
    Neumeister, P
    Holub, R
    Staber, PB
    Linkesch, W
    BLOOD, 2004, 104 (11) : 327A - 327A
  • [8] Palifermin in patients with hematological malignancies undergoing autologous hematopoietic stem cell transplantation (HSCT): The Italian Early Access Program (EAP).
    Cavagna, Laura M.
    Bonifacio, Gaetano
    Angelocci, Emanuele
    Fanni, Alessandro
    Milone, Giuseppe
    Gallo, Eugenio
    Benincasa, Elena
    BLOOD, 2006, 108 (11) : 400B - 400B
  • [9] Pain syndromes in the setting of haematopoietic stem cell transplantation for haematological malignancies
    P Niscola
    C Romani
    L Scaramucci
    T Dentamaro
    L Cupelli
    A Tendas
    D Piccioni
    M Giovannini
    B Tolu
    C Cartoni
    E Arcuri
    A Perrotti
    R Palumbo
    P de Fabritiis
    Bone Marrow Transplantation, 2008, 41 : 757 - 764
  • [10] Pain syndromes in the setting of haematopoietic stem cell transplantation for haematological malignancies
    Niscola, P.
    Romani, C.
    Scaramucci, L.
    Dentamaro, T.
    Cupelli, L.
    Tendas, A.
    Piccioni, D.
    Giovannini, M.
    Tolu, B.
    Cartoni, C.
    Arcuri, E.
    Perrotti, A.
    Palumbo, R.
    de Fabritiis, P.
    BONE MARROW TRANSPLANTATION, 2008, 41 (09) : 757 - 764
12345